ABNX France: Euronext Paris

    ABIONYX Pharma S.A.

    Back To Top
    Last Updated: Jul 23, 2021 5:35 p.m. CEDT Delayed quote


    0.01 0.59%
    Previous Close
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 105.88K 65 Day Avg: 289.03K
    37% vs Avg
    1.00 Day Range 1.06
    0.66 52 Week Range 1.50

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ABNX Overview


    5 Day
    • 10.75%
    1 Month
    • -4.28%
    3 Month
    • 1.98%
    • 4.15%
    1 Year
    • 31.38%

    Recent News

    • eLesor
    • Dow Jones

    No Headlines Available

    • Other News
    • Press Releases

    No Headlines Available

    ABIONYX Pharma S.A.

    ABIONYX Pharma SA engages in the in discovery and development of novel therapies for patients without existing or effective treatments. It specializes in the development of treatment for cardiovascular and metabolic disorders. The company was founded by Jean-Louis Dasseux and William F. Brinkerhoff on March 24, 2005 and is headquartered in Balma, France.


    Name Chg % Market Cap
    Onxeo S.A. -0.83% €55.01M
    Transgene S.A. 3.88% €221.99M
    Quantum Genomics S.A.S. -0.97%
    Competitor Data Provided ByCapital Cube Logo